TSPX was downregulated in 48 out of 51 cases (94%) with paired tumor and non-tumor lung squamous cell carcinoma samples (Wilcoxon matched pair test p-value < 0.0001). Here, TSPYL2 is linked to squamous cell lung carcinoma.